Gatifloxacin pharmacokinetics in buffalo calves after single intramuscular administration

Veterinarski Arhiv

Volumn 76, Issue 6, 2006, Pages 471-478

  Raipuria, Mukesh ^a   Dumka, Vinod Kumar ^a   Sandhu, Harpal Singh ^a   Ram, Data ^a  

^a PUNJAB AGRICULTURAL UNIVERSITY   (India)

Author keywords

Buffalo calves; Dosage; Gatifloxacin; Pharmacokinetics

Indexed keywords

EID: 33846555001     PISSN: 03725480     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ANDES, D., W. A. CRAIG (2002): Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models. Antimicrob. Agents Chemother. 46, 1665-1670.
2. ARRET, B., D. P. JOHNSON, A. KRISHBAUM (1971): Outline of details for microbiological assay of antibiotics: second revision. J. Pharm. Sci. 60, 1689-1694.
3. BAKKEN, J. S. (2004): The fluoroquinolones: how long will their utility last? Scand. J. Infect. Dis. 36, 85-92.
4. BERGOGNE-BEREZIN, E. (2002): Clinical role of protein binding of quinolones. Clin. Pharmacokinet. 41, 741-750.
5. DANIEL, A. H. (2001): New drugs of 2000. J. Am. Pharm. Assoc. 41, 229-272.
6. FISH, D. N., D. S. NORTH (2001): Gatifloxacin, an advanced 8-methoxy fluoroquinolone. Pharmacotherapy 21, 35-59.
7. nd edn. Marcel Dekker, New York. pp. 433-444.
8. GIPS, M., S. SOBACK (1996): Norfloxacin nicotinate pharmacokinetics in unweaned and weaned calves. J. Vet. Pharmacol. Therap. 19, 130-134.
9. KUNIN, C. M., R. J. DORNBUS, M. FINLAND (1959): Distribution and excretion of tetracycline analogies in normal young man. J. Clin. Invest. 38, 1950-1963.
10. th Interscience Conference on Antimicrobial Agents and Chemotherapy, 26-29 September. San Diego.
11. LUTSAR, I., I. R. FRIEDLAND, L. WUBBEL, C. C. MCCOIG, H. S. JAFRI, W. NG, F. GHAFFAR, G. H. Jr. MCCRACKEN (1998): Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 42, 2650-2655.
12. MIGNOT, A., M. GUILLME, V. BRAULT, L. GUALANO, L. MILLERIOUX, K. GOHLER, H. J. STAHLBERG (2002): Multiple-dose pharmacokinetics and excretion balance of gatifloxacin, a new fluoroquinolone antibiotic following oral administration to healthy caucasian volunteers. Chemotherapy 48, 116-121.
13. NAKASHIMA, M., T. UEMASTU, K. KOSUGE, H. KUSAJIMA, T. OOIE, Y. MASUDA, R. ISHIDA, H. UCHIDA (1995): Single and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone in humans. Antimicrob. Agents Chemother. 39, 2635-2640.
14. NAWAZ, M., H. KHAN, Z. RAHMAN (1980): Pharmacokinetics of sulfadimidine in ruminants. Proceedings of the First International Congress of Veterinary Pharmacology, Cambridge, UK, 57-63.
15. PERRY, C. M., D. ORMROD, M. HURST, S. V. ONRUST (2002): Gatifloxacin: a review of its use in the management of bacterial infectins. Drugs 62, 169-207.
16. PILLOUD, M. (1973): Pharmacokinetics, plasma protein binding and dosage of oxytetracycline in cattle and horses. Res. Vet. Sci. 15, 224-230.
17. SHOJAEE, A. F. (1997): Danofloxacin pharmacodynamic and pharmacokinetic interrelationships in ruminant species. Dissertation. University of London, UK.
18. SINGH, K., A. K. SRIVASTAVA (2000): Plasma levels, pharmacokinetics, urinary excretion and dosage regimen of ciprofloxacin in cross bred cow calves. J. Punjab Acad. Sci. 1, 105-107.
19. th Congress of European Association for Veterinary Pharmacology and Toxicology, Edinburgh, Scotland, p. 61.
20. VERMA, H. K., G. R. PANGAWAKAR, R. K. CHAUDHARY, A. K. SRIVASTAVA (1999): Pharmacokinetics and dosage regimen of enrofloxacin in buffalo bulls after intramuscular administration. Vet. Res. Commun. 23, 501-505.